Skip to main content
SpringerLink
Log in

Mutation-specific cystic fibrosis treatments on verge of approval

  • News
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rommens, J.M. et al. Science 245, 1059–1065 (1989).

    Article  CAS  Google Scholar 

  2. Riordan, J.R. et al. Science 245, 1066–1073 (1989).

    Article  CAS  Google Scholar 

  3. Kerem, B. et al. Science 245, 1073–1080 (1989).

    Article  CAS  Google Scholar 

  4. Sampson, H.M. et al. Chem. Biol. 18, 231–242 (2011).

    Article  CAS  Google Scholar 

  5. Hutt, D.M. et al. Nat. Chem. Biol. 6, 25–33 (2010).

    Article  CAS  Google Scholar 

Download references

Authors
  1. Elie Dolgin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dolgin, E. Mutation-specific cystic fibrosis treatments on verge of approval. Nat Med 17, 396–397 (2011). https://doi.org/10.1038/nm0411-396

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0411-396

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation